Non-profit · founded 1958

Analytical Services

Falls Church, United States · anser.org

Manage this page

Citations, last 5 years: 38
Works, last 5 years: 33
h-index: 45
Scientists listed: 2
Grants since 2016: 16

Grants received

2025–2026 · research · R43

A point-of-care device for the determination of homocysteine (Hcy), the Hcy Now

Robert Harper · Analytical Services · funded by National Institutes of Health

$305.4k

2023–2024 · research · R43

ADA2 Diagnostic Platform: Point-of-care test for determination of patient enzyme levels for diagnosis of the rare disease Deaminase2 Deficiency (DADA2)

Robert Harper · Analytical Services · funded by National Institutes of Health

$300k

2023–2024 · research · R43

A point of care-device for the determination of creatinine phosphokinase (CPK), the CPK Now

Robert Harper · Analytical Services · funded by National Institutes of Health

$295.9k

2023–2024 · research · R43

PKU Now-Connect: An intelligent digital ecosystem to improve health outcomes in Phenylketonuria

Robert Harper · Analytical Services · funded by National Institutes of Health

$291.4kMetabolism and Genetic Disorders

2023–2027 · research · R44

A point of care-device for the determination of creatinine phosphokinase (CPK), theCPK Now

Robert Harper · Analytical Services · funded by National Institutes of Health

$906k

2018–2022 · research · R44

A point-of-care device for phenylalanine determination

Robert Harper · Analytical Services · funded by National Institutes of Health

$944.9k

2018–2019 · grant · Standard Grant

SBIR Phase I: A user-friendly point-of-care device for simultaneous G6PDH and hemoglobin determination

Robert Harper · Analytical Services · funded by National Science Foundation

$225k

2018–2024 · research · R44

A point-of-care device for phenylalanine determination

Robert Harper · Analytical Services · funded by National Institutes of Health

$1M

2018–2019 · research · R43

A point-of-care device for phenylalanine determination

Robert Harper · Analytical Services · funded by National Institutes of Health

$224.7kMetabolism and Genetic Disorders

2018–2020 · research · R43

A point-of-care device for the determination of the Bilirubin, the BiliNow

Robert Harper · Analytical Services · funded by National Institutes of Health

$224.7kNeonatal Health and Biochemistry

2017–2021 · research · R44

A user-friendly point-of-care device for G6PDH determination

Robert Harper · Analytical Services · funded by National Institutes of Health

$574.2kNeonatal Health and Biochemistry

2017–2025 · grant · SB1

PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)

Robert Harper · Analytical Services · funded by National Institutes of Health

$982.4kNeonatal Health and Biochemistry

2017–2024 · grant · SB1

PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)

Robert Harper · Analytical Services · funded by National Institutes of Health

$990.2kNeonatal Health and Biochemistry

2017–2018 · research · R43

A user-friendly point-of-care device for G6PDH determination

Robert Harper · Analytical Services · funded by National Institutes of Health

$191.2kMalaria Research and Control

2017–2024 · grant · SB1

PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)

Robert Harper · Analytical Services · funded by National Institutes of Health

$920.6kNeonatal Health and Biochemistry

2017–2021 · research · R44

A user-friendly point-of-care device for G6PDH determination

Robert Harper · Analytical Services · funded by National Institutes of Health

$873.1kNeonatal Health and Biochemistry